| ASPR Filovirus Working Group |
Committee, Work group, Advisory group, or Task Force |
ASPR, CDC, FDA |
NIAID |
Working group focused on filoviruses. |
| ASPR H-Core for Vaccines and Therapeutics |
Committee, Work group, Advisory group, or Task Force |
ASPR, BARDA, CDC, FDA |
OD/OM, OD/OM/ORS |
The purpose of this work group/task force is to establish an HHS jurisdiction for procurement and distribution of vaccines and treatments for ongoing pandemics and outbreaks (e.g., COVID and Mpox) through the CDC. HHS and partnering agencies have essential critical infrastructure workforce staff, special patient populations, etc. that need to be treated for and/or vaccinated against dangerous pathogens and diseases. The NIH is coordinating on behalf of CDC and overseeing an independent, but collaborative, program for CDC to provide these vaccines and treatments directly to participating federal agencies for vaccination and treatment of their designated essential critical infrastructure workforce staff and special population groups such as patients enrolled in clinical trials. |
| ASPR Respiratory Protective Device (RPD) Working Group and ASPR Gowns/Gloves Workgroup |
Committee, Work group, Advisory group, or Task Force |
ASPR |
OD/OM, OD/OM/ORS |
These working groups will perform a validation process of existing and new PPE requirements in support of the upcoming MCM Preparedness Review due to Congress in 2023. This Review includes efforts historically referred to as the Strategic National Stockpile (SNS) Annual Review. |
| Assessing the Burden of Diabetes by Type in Children, Adolescents, and Young Adults Network |
Resource Development |
CDC |
NIDDK |
The primary goal of the DiCAYA network is to modernize diabetes surveillance efforts to capitalize on large-volume, electronic health record data streams and on recent advances in statistics and clinical informatics to provide accurate, timely, cost-effective, granular, and representative indicators of diabetes prevalence and incidence among children, adolescents and younger adults. The network aims to monitor overall trends as well as trends within subgroups (e.g., age, sex, diabetes type, socioeconomic status, urbanicity, geographic area). NIDDK is a DiCAYA research sponsor. |
| Assessment of Inhalation Exposures to Indoor and Occupational Aerosols |
Research Initiative |
CDC |
NIEHS |
The primary goal of this collaboration is to study inhalation exposures to indoor and occupational aerosols, with a current focus on characterizing the health hazards associated with exposure to common fungal contaminants. NIOSH uses a specially developed exposure system to conduct subchronic toxicology studies following repeated exposure to molds identified by the NTP as a public health concern. Subprojects under this IAA are examining the association of exposure to mycotoxins and health by analyzing indoor air samples, developing biomarkers of exposure and response, and using genomic sequencing methodologies to assess fungal diversity associated with the built environment. |
| Assessment of task-based exposures that may affect reproductive health in nail salon employees |
Research Initiative |
CDC |
NIEHS |
The goal of this study is to better understand a nail technician's exposure profile to select reproductive toxicants by evaluating the contributions of different tasks. |
| Bacteriophage Interest Group |
Committee, Work group, Advisory group, or Task Force |
FDA |
NIAID |
Scientific interest group discussing science and issues around bacteriophage as treatment. Includes members from FDA, BARDA, and DMID |
| BARDA ECMO Working Group |
Committee, Work group, Advisory group, or Task Force |
BARDA, FDA |
NHLBI |
Participate in scientific discussions that address challenges and opportunities for Extracorporeal Membrane Oxygenation (ECMO). |
| BARDA IL-6 and GM-CSF in Sepsis Committees |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NICHD |
These meetings with BARDA and industry discuss studies being conducted on pediatric sepsis and multiple organ dysfunction. |
| BARDA-DRIVe |
Research Initiative |
ASPR |
NIAID |
BARDA DRIVe funds early stage companies for life saving innovation. Collaboration is on agnostic pathogen detection. |